Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.320
+0.010 (0.76%)
At close: Oct 9, 2025, 4:00 PM EDT
1.320
0.00 (0.00%)
After-hours: Oct 9, 2025, 4:00 PM EDT
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $27.38 million as of October 9, 2025. Its market cap has increased by 6.61% in one year.
Market Cap
27.38M
Enterprise Value
24.56M
1-Year Change
6.61%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $27.38M, a decrease of -17.99%. That is a compound annual growth rate of -17.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 27.17M | 39.16% |
| Dec 31, 2024 | 19.53M | -41.52% |
| Sep 16, 2024 | 33.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 752.72B |
| Johnson & Johnson | 447.08B |
| AbbVie | 405.50B |
| UnitedHealth Group | 326.48B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 230.58B |